Physician profile
John Anderson
NPI 1922086743
$8,140.69
in general payments reported to CMS, 2019-2025
12 companies · $2,635 in 2025
The $2,635 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $142 · 2021: $268 · 2022: $3,820 · 2023: $246 · 2024: $272 · 2025: $2,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,595 · Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,595.00 |
| Food and Beverage | $557.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,694.79 | 2022-2023 | |
| Amgen INC. | $2,595.00 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $398.83 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $322.16 | 2019-2023 | Total30 |
| Janssen Pharmaceuticals, INC | $269.29 | 2019 | |
| Coopervision INC. | $249.56 | 2019-2021 | |
| Pfizer INC. | $201.56 | 2021-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $133.25 | 2024 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Astrazeneca Pharmaceuticals LP | $124.79 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $97.01 | 2019 | |
| Oyster Point Pharma, INC. | $41.69 | 2024 | Tyrvaya |
| Abbvie INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.